Xeris Pharmaceuticals | XERS - 税前利润



金融业
股票价格
USD
资产
USD 392.01M
现金及等价物
USD 111.75M
销售成本
USD 10.57M
流动资产
USD 251.68M
流动负债
USD 118.59M
债务
USD 258.55M
EBIT
USD 9.12M
EBITDA
USD 12.33M
员工
377
EPS每股收益
USD 0.01
股本和储备
USD 13.01M
销售毛利
USD 72.55M
债务利息支出
USD 6.88M
利息收入
USD 1.2M
贷款资金
USD 221.22M
市值
USD 1.22B
净收入
USD 2.23M
营业费用
USD 75.21M
营业利润
USD 7.92M
普通股股本
USD 172.56M
PE价格收益
76.05
税前利润
USD 2.23M
销售收入
USD 83.13M
销售和管理费用
USD 53.14M
股票
USD 74.23M
贸易债权人
USD 11.47M
应收帐款人
USD 56.3M


税前利润 更改 日
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Eli Lilly USD 8.27B 1.03B 2025-12
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Medical Developments International AUD -149K 466K 2025-06
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -921K 40.8M 2026-03
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03